Latest news with #PUNE
Yahoo
09-07-2025
- Health
- Yahoo
Spine Degenerative Disk Disease Treatment Market to Reach USD 39,589.9 Billion by 2032, Growing at a CAGR of 4.39%: Credence Research
PUNE, India, July 9, 2025 /PRNewswire/ -- According to Credence Research, the global Spine Degenerative Disk Disease Treatment Market was valued at USD 22,272.2 million in 2018 and grew to USD 28,140.7 million in 2024. The market is expected to reach USD 39,589.9 million by 2032, expanding at a steady CAGR of 4.39% during the forecast period. This growth trajectory highlights the increasing global burden of spinal disorders, particularly among aging populations, as well as the growing demand for advanced therapeutic solutions. Key factors driving market expansion include rising awareness of early intervention, increased healthcare spending, and technological advancements in surgical and non-surgical treatments. Innovations such as minimally invasive spine surgery, regenerative biologics, and next-generation spinal implants are reshaping the treatment landscape, improving clinical outcomes and patient quality of life. With a growing focus on personalized treatment and post-operative care, the Spine Degenerative Disk Disease Treatment Market continues to present strong growth opportunities across both developed and emerging regions. Browse the report and understand how it can benefit your business strategy - Key Growth Determinants – Spine Degenerative Disk Disease Treatment Market One of the primary growth drivers of the Spine Degenerative Disk Disease Treatment Market is the rising global incidence of spinal disorders, particularly among the aging population. As life expectancy increases, the prevalence of age-related degenerative conditions such as herniated discs, spinal stenosis, and osteoarthritis continues to climb, fueling demand for effective and long-lasting treatment solutions. This demographic trend, combined with a growing emphasis on maintaining mobility and quality of life in older adults, is significantly accelerating the need for both surgical and non-surgical interventions. Technological advancements in diagnostics, biologics, and minimally invasive procedures are also propelling market growth. The introduction of innovative products—such as artificial disc replacements, stem cell-based therapies, and motion-preserving implants—has transformed the treatment landscape, enabling faster recovery, reduced complications, and improved patient satisfaction. In addition, increasing investments in healthcare infrastructure, rising awareness of early diagnosis, and favorable reimbursement frameworks in key markets are supporting broader access to advanced spine care. These factors collectively position the Spine Degenerative Disk Disease Treatment Market for sustained expansion throughout the forecast period. Technological Advancements and Product Innovations – Spine Degenerative Disk Disease Treatment Market Rapid strides in medical technology and product innovation have revolutionized the treatment landscape for degenerative disk disease. Minimally invasive surgical (MIS) techniques, including percutaneous endoscopic discectomy and lateral lumbar interbody fusion (LLIF), are becoming standard practice, enabling reduced operative time, lower infection risk, and accelerated recovery. Meanwhile, the integration of robotics and image-guided navigation systems is enhancing surgical accuracy and customizable patient outcomes. On the product front, next-generation intervertebral implants—most notably artificial disc replacements and dynamic stabilizers—are gaining traction by preserving natural motion and mitigating adjacent segment degeneration. Cutting-edge biologic therapies, such as stem cell formulations, growth factors, and platelet-rich plasma (PRP), are demonstrating significant promise in promoting regeneration of disc tissue and delaying the need for surgery. Advanced biomaterials, including 3D-printed porous titanium cages and bioresorbable polymers, optimize osseointegration and biomechanical support. Collectively, these technological breakthroughs are reshaping treatment paradigms, improving clinical efficacy, and driving the premiumization and expansion of the spine degenerative disk disease therapy market. Key Growth Barriers – Spine Degenerative Disk Disease Treatment Market Despite the steady expansion of the Spine Degenerative Disk Disease Treatment Market, several factors continue to challenge its full growth potential. High treatment costs, particularly for advanced surgical procedures and novel biologics, remain a major barrier—especially in low- and middle-income regions where reimbursement coverage is limited. The financial burden associated with spinal implants, diagnostic imaging, and post-operative care often deters patients from opting for timely interventions, hindering widespread market access. Another significant constraint is the shortage of skilled spine specialists and limited access to advanced surgical infrastructure in rural and underserved areas. Delayed diagnosis, underreporting of symptoms, and patient reluctance toward invasive procedures further slow treatment uptake. In addition, long-term clinical data on the safety and efficacy of emerging regenerative therapies and motion-preserving devices is still evolving, which can impact regulatory approvals and physician adoption. These factors collectively pose challenges to the consistent and equitable growth of the market across global healthcare systems. Key Market Opportunities – Spine Degenerative Disk Disease Treatment (IBC) Market As healthcare systems focus increasingly on value-based care and preventive health strategies, early intervertebral disc (IBC) interventions present substantial market potential. Expanded screening programs and public health initiatives aimed at early detection of degenerative spine conditions could drive demand for non-invasive and minimally invasive IBC treatments, reducing surgical burden and improving long-term outcomes. Developing targeted education campaigns and collaborative care models can further boost patient engagement and facilitate seamless referral pathways from primary to specialist care. In emerging economies, growing healthcare expenditure and investments from international spine-tech companies pave the way for market penetration of advanced IBC technologies. Opportunities exist for localized production of cost-effective implants and biologics tailored to regional needs, which could dramatically improve affordability and access. Strategic partnerships with payers to include IBC procedures within reimbursement schemes, along with expanding telemedicine capabilities and mobile spine centers, would help bridge urban–rural disparities. Together, these initiatives highlight a clear avenue for growth, with the Spine Degenerative Disk Disease IBC segment poised to capitalize on both technological innovation and widening care access. Segmentation By Product: Medication Devices By Application: Cervical Spine Lumbar Spine Thoracic Spine Spinal Fusion By End User: Hospitals Ambulatory Surgical Centers Orthopedic Centers By Geography: North America Europe Asia Pacific Latin America Middle East & Africa Preview the report with a detailed sample and understand how it can benefit your business strategy. Request a free sample today - Regional Analysis – Spine Degenerative Disk Disease Treatment Market North America dominates the global market, accounting for roughly 38.5% of total revenue in 2024. Its leadership is underpinned by advanced healthcare infrastructure, significant procedure volumes, widespread adoption of minimally invasive and motion-preserving technologies, and a robust ecosystem of R&D and early reimbursement initiatives. Europe is the second-largest market, with extensive geriatric demographics and growing access to high-quality spine care. In 2018, Europe contributed USD 5.49 billion, representing about 26.7% of global market share, and remains a key region for surgical and non-surgical intervention expansion. Asia Pacific is identified as the fastest-growing region, driven by rapid development in healthcare infrastructure, rising medical awareness in populous nations such as China and India, and the increasing availability of advanced spine care facilities. The market is poised for notable traction as emerging economies embrace innovative spinal treatments. Latin America and the Middle East & Africa (MEA) are exhibiting steady gains, supported by ongoing healthcare investments, improving spine care accessibility, and increased adoption of minimally invasive surgical techniques. Latin America captured around 8.1% market share in 2018, while the Middle East and Africa combined held ~5.3%, showing potential for future growth in both regions. Credence Research's Competitive Landscape Analysis – Spine Degenerative Disk Disease Treatment Market Credence Research's competitive landscape analysis of the Spine Degenerative Disk Disease Treatment Market reveals a fragmented yet dynamic environment, led by key players such as Medtronic, Johnson & Johnson (DePuy Synthes), Stryker Corporation, Zimmer Biomet, and NuVasive. These companies are focused on expanding their product portfolios through innovation in minimally invasive techniques, biologics, and motion-preserving implants. Strategic collaborations, geographic expansion, and R&D investments remain central to maintaining competitive advantage. Emerging players are also entering the market with regenerative therapies and cost-effective solutions, intensifying competition and accelerating technological evolution across global markets. Tailor the report to align with your specific business needs and gain targeted insights. Request Sample - Key Player Analysis Medtronic Johnson and Johnson Services, Inc. Stryker Zimmer Biomet Teva Pharmaceutical Industries Endo Pharmaceuticals Mallinckrodt Pharmaceuticals Pfizer Anika Therapeutics Mesoblast Ltd Recent Industry Developments In April 2024, Johnson & Johnson launched a next-generation line of artificial discs engineered to enhance durability and optimize outcomes for patients with degenerative disc disease (DDD). In January 2023, DiscGenics Inc. received the U.S. FDA's Regenerative Medicine Advanced Therapy (RMAT) designation for its allogeneic Injectable Disc Cell Therapy (IDCT), developed to treat symptomatic lumbar DDD. In January 2023, Companion Spine LLC acquired Backbone SAS, adding the LISA implant—designed to support lumbar stiffness augmentation for DDD patients—to its product portfolio. In July 2024, Spine BioPharma, Inc. signed a collaboration agreement with Ensol BioSciences, Inc. of South Korea to broaden the indications for its investigational therapeutic, SB-01 For Injection. In September 2024, Korean firm Innosys announced the successful treatment of U.S. patients using its 3D-printed spinal implant for degenerative disc conditions, following FDA 510(k) clearance. Reasons to Purchase this Report: Gain a comprehensive understanding of the market through qualitative and quantitative analyses, considering both economic and non-economic factors, with segmentation and sub-segmentation details provided in terms of market value (USD Billion). Identify regions and segments expected to experience the fastest growth or dominate the market, with a detailed analysis of geographic consumption patterns and the factors driving or hindering market performance in each region. Stay informed about the competitive environment, with rankings of major players, recent product and service launches, partnerships, business expansions, and acquisitions from the past five years. Access detailed profiles of major market players, including company overviews, insights, product benchmarking, and SWOT analysis, to understand competitive advantages and market positioning. Explore the present and forecasted market landscape, with insights into growth opportunities, market drivers, challenges, and constraints for both developed and emerging regions. Benefit from Porter's Five Forces analysis and Value Chain insights to evaluate various market perspectives and competitive dynamics. Understand the evolving market scenario, including potential growth opportunities and trends expected in the coming years. Browse the report and understand how it can benefit your business strategy - Discover additional reports tailored to your industry needs Thoracolumbar Spine Devices Market - Spine Surgery Robots Market - Cycloidal Gear Market- Spine Implants Market - U.S. Spine Degenerative Disk Disease Treatment Market - Equine Healthcare Market - Genital Herpes Treatment Drugs Market - Osteoporosis Treatment Market - Follow Us: About Us: Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 2000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. Contact Us Mitul DeanTower C-1105 , S 25, Akash Tower,Vishal Nahar, Pimple Nilakh, Haveli,Pune – 411027, Indiasales@ Logo - View original content to download multimedia: SOURCE Credence Research Inc.
Time of India
08-07-2025
- Business
- Time of India
Emirates announces premium economy service on Kolkata route
Representative Image PUNE: Building on the successful rollout of its Premium Economy product in Mumbai, Bengaluru, and Ahmedabad, Emirates has now announced the introduction of its Premium Economy class on flights to and from Kolkata, effective July 18, airline officials said. The move marks the continued expansion of Emirates' award-winning offering across key Indian cities, with the aim of providing customers more choice when making travel plans. Passengers traveling on the Dubai-Kolkata route can now book Premium Economy seats on flight EK573, which will operate four times weekly (Wednesdays, Fridays, Saturdays and Sundays), departing Kolkata at 20:45hours and arriving in Dubai at 00:05hours. Flights to Kolkata, on EK572, depart Dubai at 13:05hours and arrive in Kolkata at 19:15hours. All times are local. Tickets can be booked immediately by visiting , for travel starting from July 18. Tickets can also be booked on Emirates App, Emirates Retail stores, Emirates contact centre, or via travel agents. Mohammad Sarhan, Emirates' VP – India and Nepal said: 'We are delighted to introduce our highly-acclaimed Premium Economy experience to Kolkata, marking another significant milestone in our commitment to the Indian market. The response to our Premium Economy product in Mumbai, Bengaluru and Ahmedabad has been overwhelmingly positive, and we are confident that travellers in Kolkata will appreciate the blend of comfort, value, and thoughtful touches that make Emirates' Premium Economy stand out. We remain dedicated to elevating the travel experience for our customers and offering them more choice and flexibility.' Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hindustan Times
13-06-2025
- General
- Hindustan Times
FYJC quota admissions: Over 9,000 seats confirmed across Maharashtra
PUNE The centralised online admission process for First-Year Junior College (FYJC) has begun across Maharashtra, with over 9,000 students confirming their admissions under various quotas in the initial phase. The general merit list, based on data provided by students in their application forms, was released on Wednesday by the higher education directorate. On Thursday, the education department received 52,468 applications under the in-house quota, of which 3,871 admissions were confirmed. Under the management quota, 36,991 applications were received, and 1,022 students finalized their admissions. The minority quota saw 23,589 applications, with 4,194 students confirming their seats. In total, 1,13,048 quota-based applications were received, and 9,087 admissions have been confirmed so far. A total of 9,435 junior colleges and higher secondary schools have registered for the first round of admissions, collectively offering 21,23,040 seats. Of these, 18,97,526 seats are available under the Centralized Admission Process (CAP), while 2,25,514 are reserved under various quotas, including minority, in-house, and management categories, stated the education directorate in its statement. As of now, 12,71,295 students have completed their registration for the centralized admission process. Quota admissions are being conducted in a separate time window — from 11 am on June 12 to 6 pm on June 14. During this period, students seeking admission under any quota must visit the respective colleges in person to confirm their seats. The education department has clarified that confirming admission under any quota is optional. However, once a student confirms admission through a quota, their name will be removed from further CAP rounds, and the seat will be considered final and non-transferable. Students have been advised to make their decision carefully before confirming a quota-based seat, said officials.
Time of India
02-06-2025
- Politics
- Time of India
Students & teachers will get to enjoy 129 off days this year in Maharastra govt school
Students & teachers will get to enjoy 129 off days this year PUNE: The school education department has announced the holiday schedule for the 2025-26 session for govt schools in Maharashtra with 129 off days for students and teachers. Schools reopen for the new academic year on June 16 in the rest of the state and on June 23 in Vidarbha. According to this new schedule, there will be 236 days of school sessions, with the remaining allocated for various holidays. Students & teachers will get to enjoy 129 off days this year in Maharastra govt school The education department finalised this timetable after discussions with teachers' associations. Last academic year, there was one less holiday compared to this year. The new session includes an extra Sunday. Throughout the year, there will be 53 Sundays which will be non-working, a govt notification stated. In February , education commissioner Sachindra Pratap Singh had said that schools would reopen on June 16 to end confusions triggered by the State Curriculum Framework for School Education (SCF-SE) that had recommended aligning Maharashtra's academic calendar with the CBSE schedule, shifting the school academic year from June-April to April-March. Education minister Pankaj Bhoyar had said that govt was considering reopening schools from April 1 for the next academic year. But, most teachers' unions opposed the move on the ground that adopting CBSE calendar without considering Maharashtra's social, cultural and geographical factors would be impractical.
Time of India
19-05-2025
- Politics
- Time of India
‘Rise above party politics on global matters': Sharad Pawar snubs Sanjay Raut over his call to boycott all-party delegation on Operation Sindoor
Sharad Pawar has publicly disagreed with Sanjay Raut's criticism of all-party delegations for Operation Sindoor, emphasizing the need to prioritize national interests over party politics in international matters. PUNE: Reacting to Shiv Sena (UBT) Rajya Sabha MP Sanjay Raut 's statement that the INDIA bloc should have boycotted all-party delegations on Operation Sindoor , NCP (SP) chief and Raut's MVA partner, Sharad Pawar , on Monday snubbed him and said that party politics should be kept aside when it comes to international issues. Pawar was interacting with the media in his hometown Baramati, where he supported the idea of sending all-party delegations to different countries to explain India's stand for undertaking Operation Sindoor following the Pahalgam terror attack. "When PV Narasimha Rao was the Prime Minister, he sent India's delegation to the UN, which was led by the then opposition leader Atal Bihari Vajpayee. I was one of the members of that delegation. What happened during Narasimha Rao's tenure is happening even today. When it comes to international issues, we should rise above party politics," Pawar said. Recently, Raut slammed the central govt over the formation of all-party delegations for Operation Sindoor, where he claimed that the central govt did not consult with any party before selecting the delegation members. He also accused the central govt of sending the all-party delegation to other countries to cover up its failure to avert the terror attack and said INDIA bloc members should have boycotted those delegations. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Ative sua licença do antivírus agora Clique aqui Undo Reacting to Raut's statement, Pawar said, "I cannot dictate my opinion to him (Raut). He has the right to express his own opinion, but I saw the name of even his party member in the delegation. My stand is clear that we should keep aside local politics while discussing international issues." On Sunday, Pawar met a group of farmers from Purandar tehsil of Pune district who are opposing a proposed international airport in their tehsil. Speaking about the meeting, Pawar said, "The central govt has finalised the site of Purandar for the international airport for Pune. However, there is farmland which was brought under the irrigation scheme when I was the chief minister, and now the farmers are growing sugarcane on that land. As the agricultural land will have to be acquired for the airport project, the farmers have certain issues with giving away their land." "Since the issue pertains to the central and state govt, my efforts are to initiate a meeting with the chief minister to discuss possible ways out. The local MP Supriya Sule , other important local members, and farmers will also participate in the meeting to find some solution," Pawar added.
